These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa). Gonzalez ME; Muttikkal TJ; Rehm PK J Radiol Case Rep; 2015 Jun; 9(6):44-9. PubMed ID: 26622936 [TBL] [Abstract][Full Text] [Related]
4. Effects of Salivary Secretion Stimulation on the Treatment of Chronic Radioactive Iodine-Induced Sialadenitis. Choi JS; Hong SB; Hyun IY; Lim JY; Kim YM Thyroid; 2015 Jul; 25(7):839-45. PubMed ID: 25809840 [TBL] [Abstract][Full Text] [Related]
8. Clinical and Sialographic Imaging Features of Wang X; Fang W; Wei L; Li B; Cheng Y J Oral Maxillofac Surg; 2021 Feb; 79(2):376-382. PubMed ID: 32896506 [TBL] [Abstract][Full Text] [Related]
9. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer. Lee SM; Lee JW; Kim SY; Han SW; Bae WK Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836 [TBL] [Abstract][Full Text] [Related]
10. Imaging-based diagnosis and classification of radioactive iodine-induced sialadenitis. Li X; Zheng DN; Ling XT; Yang J; Xie XY; Liu DG; Yu GY Oral Dis; 2024 Oct; 30(7):4303-4311. PubMed ID: 38073152 [TBL] [Abstract][Full Text] [Related]
11. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Almeida JP; Sanabria AE; Lima EN; Kowalski LP Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917 [TBL] [Abstract][Full Text] [Related]
12. Persistent sialadenitis after radioactive iodine therapy: report of two cases. Mandel SJ; Mandel L J Oral Maxillofac Surg; 1999 Jun; 57(6):738-41. PubMed ID: 10368102 [No Abstract] [Full Text] [Related]
13. Dramatic parotid uptake of I-131 on a diagnostic whole-body scan. Carlisle MR; McDougall IR Clin Nucl Med; 2000 Nov; 25(11):895-7. PubMed ID: 11079586 [TBL] [Abstract][Full Text] [Related]
14. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment. Geres AE; Mereshian PS; Fernández S; Rey Caro DG; Castro R; Podio R; Ojeda S Endocrinol Nutr; 2015 Dec; 62(10):493-8. PubMed ID: 26459118 [TBL] [Abstract][Full Text] [Related]
16. [Mucoepidermoid carcinoma of the submandibular gland after high-dose radioiodine therapy: case report and review of the literature]. Henze M; Hittel JP; Elser H Nuklearmedizin; 1998 Jan; 37(1):45-9. PubMed ID: 9467170 [TBL] [Abstract][Full Text] [Related]
17. Unusual patterns of I-131 accumulation. Ozguven M; Ilgan S; Karacalioglu AO; Arslan N; Ozturk E Clin Nucl Med; 2004 Nov; 29(11):738-40. PubMed ID: 15483496 [No Abstract] [Full Text] [Related]
18. Comparison of 30 mCi and 50 mCi I-131 doses for ablation of thyroid remnant in papillary thyroid cancer patients. Cai XY; Vijayaratnam N; McEwan AJB; Reif R; Morrish DW Endocr Res; 2018 Feb; 43(1):11-14. PubMed ID: 28742421 [TBL] [Abstract][Full Text] [Related]
19. Sialadenitis following radioiodine therapy - a new diagnostic and treatment modality. Nahlieli O; Nazarian Y Oral Dis; 2006 Sep; 12(5):476-9. PubMed ID: 16910918 [TBL] [Abstract][Full Text] [Related]
20. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases. Bricout P; Kibler RS J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908 [No Abstract] [Full Text] [Related] [Next] [New Search]